FDA approves first generic EpiPen in blow to Mylan

fda approves first generic epipen in blow to mylan

The EpiPen is getting competition. The Food and Drug Administration has approved what it described as the first official generic version of the EpiPen, a life-saving treatment for severe allergic reactions. The generic device's maker, Teva Pharmaceuticals, is a rival to Mylan's brand-name version.

FDA approves first generic EpiPen in blow to Mylan

FDA approves first generic EpiPen in blow to Mylan
FDA approves first generic EpiPen in blow to Mylan FDA approves first generic EpiPen in blow to Mylan FDA approves first generic EpiPen in blow to Mylan FDA approves first generic EpiPen in blow to Mylan FDA approves first generic EpiPen in blow to Mylan FDA approves first generic EpiPen in blow to Mylan

 

 

Read Full Article on The Souce

Author: HEDGE

Hedge Accordingly was founded ahead of the global financial crisis in January of 2008, with the goal of providing our readers our unique take on The Latest News on Wall Street, Stocks, #Politics and Business news. Hedge Accordingly produces both original, and aggregated #Wallst news content from top publishers around the world. We curate aggregated content covering the latest news on politics, stocks, wall street, and the tech industry. We also provide free stock charting, quotes and a bitcoin, forex and currency exchange. Learn More About HEDGEaccordingly.com